Manuscripts
Showing 1556 manuscripts.
Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature
Citation
Julie Nelson, Amy M. Loftis, Wafaie Fawzi, Taha El Tahir Taha, Robert Goldenberg, Susan A. Fiscus. Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature. Journal of Clinical Microbiology. 2009. 47: 1209-11. PMID: 19225101Year
2009
Journal
Journal of Clinical Microbiology
Mental health treatment patterns in perinatally HIV-infected youth and controls
Citation
Kenneth D. Gadow, Miriam Chernoff, Pim Brouwers, Edward V. Morse, Jerry D. Heston, Janice Hodge, Vincenza M. Di Poalo, Nagamah Sandra Deygoo, Sharon Appelbaum Nachman. Mental health treatment patterns in perinatally HIV-infected youth and controls. Pediatrics. 2009. 124: 627-36. PMID: 19596734Year
2009
Journal
Pediatrics
Study
P1055
Zidovudine, Lamivudine and Nelfinavir Concentrations in Amniotic Fluid and Maternal Serum
Citation
Chantelle Bennetto-Hood, Yvonne J. Bryson, Alice M. Stek, Jennifer R. King, Mark Mirochnick, Edward P. Acosta. Zidovudine, Lamivudine and Nelfinavir Concentrations in Amniotic Fluid and Maternal Serum. HIV Clinical Trials. 2009. 10: 41-7. PMID: 19362995Year
2009
Journal
HIV Clinical Trials
Virologic and Immunologic Correlates with the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on HAART
Citation
Adriana Weinberg, Sharon Huang, Terence Fenton, Julie A. Patterson, Philimon Gona, Jennifer S. Read, Wayne M. Dankner, Sharon Appelbaum Nachman. Virologic and Immunologic Correlates with the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on HAART. Journal of Acquired Immune Deficiency Syndromes. 2009. 51: 54-9. PMID: 19617848Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1008
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy antiretroviral Therapy.
Citation
Allison Agwu, Jane C. Lindsey, Kimberly Ferguson, Hao Zhang, Stephen A. Spector, Bret J. Rudy, Stuart C. Ray, Steven D. Douglas, Patricia M. Flynn, Deborah Persaud. Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy antiretroviral Therapy.. AIDS Patient Care and STDs. 2009. 22: 545-52.Year
2009
Journal
AIDS Patient Care and STDs
Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes
Citation
Donald Campbell, Nancy Tustin, Eric Riedel, Richard Tustin, Jonathan Taylor, Steven D. Douglas, J. Edward Murray. Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes. Clinical and Vaccine Immunology. 2009. 16: 1648-53. PMID: 19726615Year
2009
Journal
Clinical and Vaccine Immunology
The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.
Citation
Kathleen Malee, Paige L. Williams, Grace Montepiedra, Sharon L. Nichols, Patricia Sirois, Deborah S. Storm, John J. Farley, Betsy Kammerer. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.. Journal of Pediatric Psychology. 2009. 34: 165-75. PMID: 18647794Year
2009
Journal
Journal of Pediatric Psychology
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Citation
Christina M. Marra, Yu Zhao, David B. Clifford, Scott L. Letendre, Scott Evans, Kate Henry, Ronald J. Ellis, Benigno Rodriguez, Robert W. Coombs, Giovanni Schifitto, Justin C. McArthur, Kevin R. Robertson. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009. 23: 1359-66. PMID: 19424052Year
2009
Journal
AIDS
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
Citation
Philip Keiser, David Alain Wohl, Michelle A. Kendall, Janet Andersen, Clyde S. Crumpacker, Stephen A. Spector, Judith Feinberg, Beverly L. Alston-Smith, Susan Owens, Suzette A. Chafey, Michael Marco, Sharon D. Maxwell-Henkel, Nell Lurain, Douglas Jabs, Constance A. Benson. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.. HIV Clinical Trials. 2009. 10: 143-52. PMID: 19632953Year
2009
Journal
HIV Clinical Trials
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)
Citation
David B. Clifford, Scott Evans, Yijun Yang, Edward P. Acosta, Heather Ribaudo, Roy (Trip) Gulick. Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clinical Trials. 2009. 10: 343-55.Year
2009
Journal
HIV Clinical Trials